In the largest comparison of angiotensin receptor blockers (ARBs) and angiotensin-converting enzyme (ACE) inhibitors to date, a study of nearly 2.3 million patients starting the drugs as monotherapy ...
A series of papers published in recent days provide reassuring data that patients taking inhibitors of the renin-angiotensin-aldosterone system (RAAS), such as ACE inhibitors and angiotensin receptor ...
Close-up of senior black woman sorting weekly medication. Member of a black middle class America family. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the ...
In more than 3 million people worldwide treated for hypertension, ARBs were not only just as effective as ACE inhibitors at reducing the risk of major cardiovascular events, but also associated with a ...
May 5 (UPI) --Certain high blood pressure medications have been linked with more serious illness from COVID-19, but they don't increase a person's risk for getting the disease, a new study published ...
The first study of its kind reports that patients should keep taking well-known heart medications. Patients with heart conditions that require angiotensin-converting enzyme (ACE) inhibitors and ...
Credit: Getty Images. Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines. Angiotensin receptor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results